CTRI/2021/04/033014已完成3 期
Clinical study to evaluate the efficacy and safety of vitimelin tablet and vitimelin oil in vitiligo w.s.r. to shwitra
DrVasishths Ayuremedies0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1-Children of either gender aged group between 10 - 16 years.
- •2- Children having classical sign and symptom and diagnosed as vitiligo / Shwitra.
- •3- Patient should be capable of obeying the instruction related to course of therapy.
排除标准
- •1- Children below 10 years and above 16 years of age.
- •2- Patches more than 30% of the body, Broad continuous irregular patches.
- •3- Children with albinism will be excluded.
- •4- White anesthetic spot which are characterized of leprosy.
- •5- Patches in genital area and only lip area are excluded from the study.
- •6- Patient not fulfilling the inclusion criteria.
- •7- Patient suffering from any other known systemic and chronic disease / Autoimmune
- •8- Patient not willing to give consent for participation in the Research study.
研究者
相似试验
未知
3 期
Clinical study to evaluate the efficacy and safety of TA-650 in patients with psoriasisPsoriasisJPRN-jRCT2080220313Mitsubishi Tanabe Pharma Corporation
已完成
2 期
A study for Under eye dark circlesCTRI/2022/09/045732Transformative Learning Solutions Pvt Ltd32
进行中（未招募）
不适用
Clinical study to evaluate the efficacy and safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in adults. - N/AEUCTR2005-003552-35-DEOctapharma AG116
已完成
2 期
Clinical study on Dabur gel in reduction of oral malodor.CTRI/2021/07/034750Dabur India limited161
进行中（未招募）
不适用
Clinical study to evaluate the efficacy and safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in adults. - N/AIdiopathic thrombocytopenic purpura, in adults actively bleeding or at high risk bleeding.MedDRA version: 7.0Level: LLTClassification code 10021245EUCTR2005-003552-35-ATOctapharma AG116